Giant cell arteritis

Julie Falardeau1

  • 1Casey Eye Institute, Oregon Health and Science University, 3303 South West Bond Avenue, Portland, OR 97239, USA. falardea@ohsu.edu

Neurologic Clinics
|July 20, 2010
PubMed

Insights

Giant cell arteritis is a medical emergency requiring prompt diagnosis and treatment to prevent permanent vision loss. Corticosteroids remain the primary treatment for this systemic vasculitis.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Neurology

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis with diverse clinical presentations.
  • It poses a significant risk of profound and irreversible visual loss.
  • GCA is considered a medical emergency due to potential complications.

Purpose of the Study:

  • To emphasize the critical need for prompt diagnosis and treatment of GCA.
  • To highlight the importance of early intervention in preventing visual and neurologic deficits.
  • To underscore the role of specific diagnostic and therapeutic modalities.

Main Methods:

  • Clinical assessment for suspected GCA.
  • Performance of temporal artery biopsy for diagnostic confirmation.
  • Initiation of corticosteroid therapy as the primary treatment.

Main Results:

  • Prompt diagnosis and treatment are crucial for mitigating severe outcomes.
  • Temporal artery biopsy is a key diagnostic tool.
  • Corticosteroids are the established mainstay of GCA management.

Conclusions:

  • Early recognition and management of GCA are imperative.
  • Aggressive treatment is necessary to prevent devastating complications like blindness.
  • Corticosteroid therapy remains the cornerstone of GCA treatment.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...